Shares of Sangamo Therapeutics Inc. (NASDAQ: SGMO) plummeted by 50.85% as Pfizer Inc. (NYSE: PFE) terminated their hemophilia A gene therapy co-development agreement.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
SGMO Pre-Market Shares Drop 40% Over Pfizer (PFE) Deal Collapse
